Michael Hal Weiner - 10 Mar 2026 Form 4 Insider Report for Genpact LTD (G)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Mar 2026, 16:14:27 UTC
Prior SEC filing
05 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Michael Hal Weiner

Key filing fact

Michael Hal Weiner filed Form 4 for Genpact LTD (G) on 12 Mar 2026.

Key facts

  • This page summarizes Michael Hal Weiner's Form 4 filing for Genpact LTD (G).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Mar 2026, 16:14.

Change

  • Previous filing in this sequence was filed on 05 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001591621 Primary reporting owner

Weiner Michael Hal

Relationship
Chief Financial Officer
Address
C/O GENPACT LLC, 521 FIFTH AVENUE, 14TH FLOOR, NEW YORK
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Michael Hal Weiner
Signature date
12 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

G transaction

Common Shares

Tax liability

Transaction value
Shares
-7,019
Change %
-3.7%
Price
$38.92*
Shares after
181,874
Date
10 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of performance share units granted on March 15, 2023 under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .